Kera Capital Partners’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$116K Hold
13,000
– – 0.01% 680
2026
Q2
$134K Hold
13,000
– – 0.01% 622
2026
Q1
$118K Hold
13,000
– – 0.01% 559
2025
Q4
$75.8K Buy
+13,000
New +$53.5K 0.01% 545

Other funds holding IMMX

Kera Capital Partners's IMMX Position: Q3 2026 in Review

Kera Capital Partners held its Immix Biopharma (IMMX) position steady in Q3 2026 at 13,000 shares worth $116K. The position accounts for 0.01% of the portfolio, ranked #680.

Kera Capital Partners first reported a position in IMMX in Q4 2025 and has held it in 4 quarters since. The position peaked at $134K in Q2 2026. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Kera Capital Partners held 13,000 shares of Immix Biopharma worth $116K as of Q3 2026.
  • Kera Capital Partners left its Immix Biopharma share count unchanged in Q3 2026.
  • Immix Biopharma made up 0.01% of Kera Capital Partners's portfolio in Q3 2026, its #680 holding.
  • Kera Capital Partners first reported a position in Immix Biopharma in Q4 2025 and has held it in 4 quarters since.
  • Kera Capital Partners's Immix Biopharma position peaked at $134K in Q2 2026.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Kera Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.